Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Amortization of Deferred Charges (2019 - 2021)

UroGen Pharma's Amortization of Deferred Charges history spans 3 years, with the latest figure at $232000.0 for Q2 2021.

  • For Q2 2021, Amortization of Deferred Charges fell 38.79% year-over-year to $232000.0; the TTM value through Jun 2021 reached $1.3 million, up 4.19%, while the annual FY2020 figure was $1.6 million, 58.37% up from the prior year.
  • Amortization of Deferred Charges reached $232000.0 in Q2 2021 per URGN's latest filing, down from $237000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $494000.0 in Q4 2020 to a low of $232000.0 in Q2 2021.
  • Average Amortization of Deferred Charges over 3 years is $312500.0, with a median of $269000.0 recorded in 2019.
  • Peak YoY movement for Amortization of Deferred Charges: soared 69.18% in 2020, then crashed 38.79% in 2021.
  • A 3-year view of Amortization of Deferred Charges shows it stood at $292000.0 in 2019, then skyrocketed by 69.18% to $494000.0 in 2020, then crashed by 53.04% to $232000.0 in 2021.
  • Per Business Quant, the three most recent readings for URGN's Amortization of Deferred Charges are $232000.0 (Q2 2021), $237000.0 (Q1 2021), and $494000.0 (Q4 2020).